Microbiome Therapeutics: Global Markets

Report Scope:

This new report, Microbiome Therapeutics: Global Markets, provides a comprehensive analysis of the microbiome therapeutics market in global context, including market forecasts and sales through 2025. The report analyzes the market by segmenting it into the various types of microbiome therapeutics, based on the strategies used for treatment: additive (fecal matter transplants or FMTs, live biotherapeutic products or LBPs), modulatory (postbiotics, prebiotics) and subtractive microbiome therapeutics (phages and antimicrobials). This study surveys the microbiome therapeutics market by application or disease segments: infectious diseases, metabolic diseases, cancer, gut-brain axis and others. The market is also assessed in the following geographic regions: North America, Europe and emerging markets. Emerging markets include countries like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada and Latin America.

The report features leading clinical trials indicating the status and phase of development. New developments and patents are boosting the growth of this market in the global context.

The new BCC report provides comprehensive profiles of market players in the industry. The industry structure chapter focuses on the changing market trends, market players and their leading pipeline candidates. This chapter also covers the mergers and acquisitions and any other collaborations or partnerships that happened during the evaluation period of this report that are expected to shape the industry.

Factors such as strengths, weaknesses, threats and opportunities that are expected to play a role in the microbiome therapeutics market are evaluated in detail.

Excluded from this report are the markets for prebiotics and probiotics labeled as nutritional or dietary supplements. Prebiotics and probiotics, if included, only pertain to when used in the context of microbiome therapy.

Report Includes:

- 32 data tables and 47 additional tables
- An in-depth overview of the global microbiome therapeutics market
- Analyses of the global market trends, with data corresponding to market size for 2021-2025, and projections of compound annual growth rates (CAGRs) through 2026
- Latest information on market drivers and opportunities, challenges and restraints, technological developments, and regulatory updates, along with their impact on the stakeholders in this market
- Evaluation of market potential for microbiome therapeutics market, their market share analysis on the basis of product types, applications, and regions
- Highlights of this innovation driven microbiome therapeutics market covering current trends, disease areas of application, clinical trials and their stages, and new developments
- Impact of COVID-19 pandemic on the global economy and delay in the clinical trial activity and financial effects on the overall growth of this market
- Competitive landscape of this market featuring leading biopharmaceutical companies, their products pipeline and company share analysis
- Key merger and acquisition deals, collaborations and partnerships, licensing and manufacturing agreements, and other notable investment strategies within this market
- Patent review and deep-dive of the issued patents on the basis of categories such as type, year, disease type, company, country, and assignee
- Profile description of the major market participants, including Azitra Inc., Evelo Biosciences, LNC Therapeutics, Second Genome and Vedanta Biosciences Inc.

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Key Highlights
Chapter 3 Market and Technology Background
The Human Microbiome
The Different Microbiomes in Humans
Microbiome and Human Health and Disease
Technologies Aiding Microbiome Research
Microbiome Research Projects
Microbiome Therapeutics
Strategies for Development of Microbiome Therapeutics
Microbiome Therapeutics Disease Areas
Regulatory Landscape for Microbiome Therapeutics
Chapter 4 Market Breakdown by Technology Type
Market by Microbiome Strategy Type
Market Overview
Additive Microbiome Therapeutics
Modulatory Microbiome Therapeutics
Subtractive Microbiome Therapeutics
Chapter 5 Market Breakdown by Application
Market by Disease Type
Market Overview
Market Revenue
Market Shares
Infections
Gastrointestinal (GIT) Diseases
Metabolic Diseases
Cancer
Gut-Brain Axis Diseases
Other Diseases
Market by Region
Market Shares
Chapter 6 Industry Structure
Investment in Microbiome Therapeutics
Public Funding Initiatives
Private Funding Initiatives
Collaborations and Partnerships
Licensing and Manufacturing Agreements
Mergers and Acquisitions
Leading Market Players in Microbiome Therapeutics Market
Leading Market Players in Additive Microbiome Therapeutics Market
Leading Market Players in Modulatory Microbiome Therapeutics Market
Leading Market Players in Subtractive Microbiome Therapeutics Market
BCC Research Select Insights from Industry Leaders
Chapter 7 Patent Analysis
Patent Analysis
Patents by Year
Patents by Type
Patents by Disease Type
Patents by Company
Patents by Country
Patents by Assignee
Chapter 8 Clinical Trial Analysis
Clinical Trial Analysis by Disease Category
Share of Clinical Trials
Clinical Trial Analysis by Treatment Strategy
Share of Clinical Trials
Clinical Trial Analysis by Company
Share of Clinical Trials
Microbiome Therapeutics in Discovery and Preclinical Development
Microbiome Therapeutics Clinical Trials in Phase 3
Chapter 9 Analysis of Market Opportunities
SWOT Analysis
Strengths of Microbiome Therapeutics Market
Challenges for Microbiome Therapeutics Market
Opportunities for Microbiome Therapeutics Market
Threats to the Microbiome Therapeutics Market
Chapter 10 Company Profiles
4D PHARMA
AO BIOME LLC
ASSEMBLY BIOSCIENCES INC.
ARMATA PHARMACEUTICALS
AZITRA INC.
BIOMICA
BIOMX
CHAIN BIOTECHNOLOGY LTD.
ELIGO BIOSCIENCE SAS
ENTEROME SA
EVELO BIOSCIENCES
FINCH THERAPEUTICS GROUP INC.
INTRALYTIX INC.
KALEIDO BIOSCIENCES
KINTAI THERAPEUTICS INC.
LNC THERAPEUTICS INC.
MAAT PHARMA
OSEL INC.
PYLUM BIOSCIENES INC.
QUORUM INNOVATIONS LLC
REBIOTIX INC. (ACQUIRED BY FERRING PHARMACEUTICALS)
SECOND GENOME
SERES THERAPEUTICS INC.
SFA THERAPEUTICS INC.
SYNLOGIC
SYNTHETIC BIOLOGICS INC.
VEDANTA BIOSCIENCES INC.
Chapter 11 Appendix: Acronyms

List Of Tables


Summary Table : Global Market for Microbiome Therapeutics, by Disease Type, Through 2026
Table 1 : Technologies for Microbiome Research
Table 2 : Dysbiosis in Microbiome
Table 3 : Leading Pharmaceuticals in Microbiome Therapeutics Partnerships
Table 4 : Global Market for Microbiome Therapeutics, by Strategy Type, Through 2026
Table 5 : Global Market Shares of Microbiome Therapeutics, by Strategy Type, 2024
Table 6 : LBPs in Microbiome Therapeutics
Table 7 : Global Market for Additive Microbiome Therapeutics, by Type, Through 2026
Table 8 : Global Market Shares of Additive Microbiome Therapeutics, by Type, 2024
Table 9 : Modulatory Microbiome Therapeutics
Table 10 : Global Market for Modulatory Microbiome Therapeutics, by Type, Through 2026
Table 11 : Global Market Shares of Modulatory Microbiome Therapeutics, by Type, 2024
Table 12 : Global Market for Subtractive Microbiome Therapeutics, by Type, Through 2026
Table 13 : Global Market Shares of Subtractive Microbiome Therapeutics, by Type, 2024
Table 14 : R&D Expenditures in Microbiome Therapeutics, by Company, 2017-2019
Table 15 : Global Market for Microbiome Therapeutics, by Disease Type, Through 2026
Table 16 : Global Market Shares of Microbiome Therapeutics, by Disease Type, 2024
Table 17 : Microbiome Therapeutics in Infections
Table 18 : Global Market for Microbiome Therapeutics for Infections, by Region, Through 2026
Table 19 : Microbiome Therapeutics in GIT Diseases
Table 20 : Global Market for Microbiome Therapeutics for GIT Diseases, by Region Through 2026
Table 21 : Microbiome Therapeutics in Metabolic Diseases
Table 22 : Global Market for Microbiome Therapeutics for Metabolic Diseases, by Region, Through 2026
Table 23 : Microbiome Therapeutics in Cancer
Table 24 : Global Market for Microbiome Therapeutics for Cancer, by Region, Through 2026
Table 25 : Microbiome Therapeutics in Gut-Brain Axis Diseases
Table 26 : Global Market for Microbiome Therapeutics for Gut-Brain Axis Diseases, by Region, Through 2026
Table 27 : Microbiome Therapeutics in Other Diseases
Table 28 : Global Market for Microbiome Therapeutics for Other Diseases, by Region, Through 2026
Table 29 : Global Market for Microbiome Therapeutics, by Region, Through 2026
Table 30 : Global Market Shares of Microbiome Therapeutics, by Region, 2024
Table 31 : Historical Funding Activity in Microbiome Therapeutics, 2015 and 2016
Table 32 : Public Funding in Microbiome Therapeutics, 2018-August 2020
Table 33 : Venture Funding in Microbiome Therapeutics, 2017-August 2020
Table 34 : Collaborations and Partnerships in the Microbiome Therapeutics Market, 2017-August 2020
Table 35 : Licensing and Manufacturing Agreements in the Microbiome Therapeutics Market, 2017-August 2020
Table 36 : Leading Developers of Additive Microbiome Therapeutics, 2019
Table 37 : Leading Developers of Modulatory Microbiome Therapeutics, 2019
Table 38 : Leading Developers of Subtractive Microbiome Therapeutics, 2019
Table 39 : Patents Issued for Microbiome Therapeutics, by Year, 2017-August 2020
Table 40 : Patents Issued for Microbiome Therapeutics, by Type, 2017-August 2020
Table 41 : Patents Issued for Microbiome Therapeutics, by Disease Type, 2017-August 2020
Table 42 : Patents Issued for Microbiome Therapeutics, by Company, 2017-August 2020
Table 43 : Patents Issued for Microbiome Therapeutics, by Country, 2017-August 2020
Table 44 : Patents Issued for Microbiome Therapeutics, by Assignee, 2017-August 2020
Table 45 : Clinical Trials in Microbiome Therapeutics, by Disease Type, August 2020
Table 46 : Share of Clinical Trials in Microbiome Therapeutics, by Disease Type, August 2020
Table 47 : Clinical Trials in Microbiome Therapeutics, by Treatment Strategy
Table 48 : Share of Clinical Trials in Microbiome Therapeutics, by Treatment Strategy
Table 49 : Clinical Trials in Microbiome Therapeutics, by Company
Table 50 : Share of Clinical Trials in Microbiome Therapeutics, by Top 10 Companies
Table 51 : Microbiome Therapeutics in Discovery and Preclinical Development
Table 52 : Microbiome Therapeutics Clinical Trials in Phase 3
Table 53 : 4D Pharmas Pipeline
Table 54 : AO Biomes Pipeline
Table 55 : Assembly Biosciences Pipeline
Table 56 : Armata Pharmaceuticals Pipeline
Table 57 : Azitras Pipeline
Table 58 : Biomicas Pipeline
Table 59 : BiomXs Pipeline
Table 60 : Chain Biotechnologys Pipeline
Table 61 : Enteromes Pipeline
Table 62 : Evelo Biosciences Pipeline
Table 63 : Finch Therapeutics Pipeline
Table 64 : Intralytixs Pipeline
Table 65 : Kaleido Biosciences Pipeline
Table 66 : Kintai Therapeutics Pipeline
Table 67 : LNC Therapeutics Pipeline
Table 68 : MaaT Pharmas Pipeline
Table 69 : Osels Pipeline
Table 70 : Quorum Innovations Pipeline
Table 71 : Rebiotixs Pipeline
Table 72 : Second Genomes Pipeline
Table 73 : Seres Therapeutics Pipeline
Table 74 : SFA Therapeutics Pipeline
Table 75 : Synlogics Pipeline
Table 76 : Synthetic Biologics Pipeline
Table 77 : Vedanta Biosciences Pipeline
Table 78 : Acronyms Used in Microbiome Therapeutics

List Of Figures


Summary Figure : Global Market for Microbiome Therapeutics, by Disease Type, 2021-2026
Figure 1 : Differences in Human Genome and Microbiome
Figure 2 : Bacterial Distribution, by Body Site
Figure 3 : Essential Functions of Human Microbiome
Figure 4 : Dysbiosis and Human Health
Figure 5 : Summary of NIH Funding for Microbiome Research, 2012-2016
Figure 6 : Global Market for Microbiome Therapeutics, by Strategy Type, 2021-2026
Figure 7 : Global Market Shares of Microbiome Therapeutics, by Strategy Type, 2024
Figure 8 : Global Market for Additive Microbiome Therapeutics, by Type, 2021-2026
Figure 9 : Global Market Shares of Additive Microbiome Therapeutics, by Type, 2024
Figure 10 : Global Market for Modulatory Microbiome Therapeutics, by Type, 2021-2026
Figure 11 : Global Market Shares of Modulatory Microbiome Therapeutics, by Type, 2024
Figure 12 : Global Market for Subtractive Microbiome Therapeutics, by Type, 2021-2026
Figure 13 : Global Market Shares of Subtractive Microbiome Therapeutics, by Type, 2024
Figure 14 : Global Market for Microbiome Therapeutics, by Disease Type, 2021-2026
Figure 15 : Global Market Shares of Microbiome Therapeutics, by Disease Type, 2024
Figure 16 : Global Market for Microbiome Therapeutics for Infections, by Region, 2021-2026
Figure 17 : Global Market for Microbiome Therapeutics for GIT Diseases, by Region, 2021-2026
Figure 18 : Global Market for Microbiome Therapeutics for Metabolic Diseases, by Region, 2021-2026
Figure 19 : Global Market for Microbiome Therapeutics for Cancer, by Region, 2021-2026
Figure 20 : Global Market for Microbiome Therapeutics for Gut-Brain Axis Diseases, by Region, 2021-2026
Figure 21 : Global Market for Microbiome Therapeutics for Other Diseases, by Region, 2021-2026
Figure 22 : Global Market for Microbiome Therapeutics, by Region, 2021-2026
Figure 23 : Global Market Shares of Microbiome Therapeutics, by Region, 2024
Figure 24 : Patents Issued for Microbiome Therapeutics, by Year, 2017-August 2020
Figure 25 : Patents Issued for Microbiome Therapeutics, by Type, 2017-August 2020
Figure 26 : Patents Issued for Microbiome Therapeutics, by Disease Type, 2017-August 2020
Figure 27 : Patents Issued for Microbiome Therapeutics, by Company, 2017-August 2020
Figure 28 : Patents Issued for Microbiome Therapeutics, by Country, 2017-August 2020
Figure 29 : Patents Issued for Microbiome Therapeutics, by Assignee, 2017-August 2020
Figure 30 : Share of Clinical Trials in Microbiome Therapeutics, by Disease Type, August 2020
Figure 31 : Share of Clinical Trials in Microbiome Therapeutics, by Treatment Strategy
Figure 32 : Share of Clinical Trials in Microbiome Therapeutics, by Top 10 Companies
Figure 33 : SWOT Analysis of the Microbiome Therapeutics Market

Microbiome Therapeutics: Global Markets

Report Scope:This new report, Microbiome Therapeutics: Global Markets, provides a comprehensive analysis of the microbiome therapeutics market in global context, including market forecasts and sales through 2025. The report analyzes

USD 5500 View Report

Global Microbiome Partnering Terms and Agreements 2014 to 2019

Global Microbiome Partnering Terms and Agreements 2014 to 2019 market research report available in single user pdf license with Aarkstore Enterprise at USD 1995

USD 1995 View Report

Colorectal Cancer Therapeutics: Global Markets

Report Scope:This report is a business analysis that examines market trends for colorectal cancer therapeutics. The report includes sections on the following topics - - Current prevalence of colorectal cancer,

USD 5500 View Report

Blood Cancer Therapeutics: Global Markets to 2023

Report ScopeThis report organizes information from diverse sources into a comprehensive report that includes an overview, market dynamics, disease type, leading blockbuster drug profiles, regulations, reimbursement and patents. It analyzes

USD 2750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available